Coherus Oncology Inc (CHRS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Coherus Oncology inc   (NASDAQ: CHRS)
 

Coherus Oncology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Coherus Oncology Inc 's inventory turnover ratio sequentially decreased to 4.03 in the second quarter 2026, otherwise the ratio remained above the average, as CHRS's markets remain strong.Coherus Oncology Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 91 days, from 89 days, in the Mar 31 2026 quarter.

Within Healthcare sector 97 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 968, from total ranking in the first quarter 2026 at 1067.

CHRS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Coherus Oncology Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CHRS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 25.57 % 37.15 % -95.47 % -95.7 % -92.74 %
Y / Y Cost of Sales Growth 24.95 % 43.76 % -88.05 % -82.06 % -88.03 %
Inventory Turnover Ratio (TTM) 4.03 4.11 4.17 2.18 1.93
CHRS's Total Ranking # 968 # 1067 # 1537 # 1630 # 1644
Average inventory processing period 91 89 88 168 189
Seq. Inventory Growth 17.45 % 52.11 % 54.88 % -54.62 % 28.28 %
Seq. Cost of Sales Growth 11.22 % -5.71 % 8.71 % 9.6 % 27.97 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 9
Healthcare Sector # 98
Overall Market # 968

Inventory Turnover Ratio Statistics
High Average Low
4.17 1.98 0.71
(Dec 31 2025)   (Sep 30 2019)



CHRS Company Profile >> Back to CHRS Efficiency Comparisons >> Compare CHRS Inventory Turnover Ratio to its Competitors

Financial Statements
Coherus Oncology Inc 's Inventories $ 6 Millions Visit CHRS's Balance sheet
Coherus Oncology Inc 's Cost of Revenues TTM $ 16 Millions Visit CHRS's Income Statement
What are CHRS's Sales? Visit CHRS's Sales by Segment

Other Inventory Turnover Ratios
Coherus Oncology Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CHRS's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CHRS's Competitors
Inventory Turnover Ratio for CHRS's Suppliers
Inventory Turnover Ratio for CHRS's Customers

You may also want to know
CHRS's Sales Growth Rates CHRS's Pe Price to earnings ratio CHRS's Receivables Turnover Ratio CHRS's Stock Quote
CHRS's Net Income Growth Rates CHRS's Ps Price to Sales ratio CHRS's Sales per Employee CHRS's Asset Turnover Ratio
CHRS's Net Margin CHRS's Pb Price to Book ratio CHRS's Financial Strength Ratios CHRS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions

Date modified: 2026-09-11T07:12:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.